Jay B. Shah

FDA investigator

Appears on 5 documents from 2021 to 2026, mostly at sites in New Jersey. Most often cites responsibilities of quality control unit (21 CFR 211.22).

5
Documents on file
4.6
Observations per 483
2021
First seen
2026
Most recent

What they cite most

From 23 observations

Activity by year

2021: 2, 2022: 2, 2026: 1

Where

New Jersey 5

Is Jay B. Shah coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

5 documents, newest first
FirmOpen
483 BeOne Medicines USA, Inc.Feb 17, 2026 · Pennington, New Jersey
483 Cyalume Specialty Products IncOct 3, 2022 · Bound Brook, New Jersey
483 Hikma Injectables USA Inc.Jun 8, 2022 · Dayton, New Jersey
483 Aurolife Pharma LLCDec 7, 2021 · Dayton, New Jersey
483 Tris Pharma IncJun 8, 2021 · Monmouth Junction, New Jersey

About this profile

What does Jay B. Shah inspect?

Jay B. Shah appears on 5 documents on file covering 5 sites, mostly in New Jersey.

What do they cite most often?

21 CFR 211.22 (responsibilities of quality control unit), followed by 21 CFR 211.67(a) and 21 CFR 211.160.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Jay B. Shah is dated Feb 17, 2026.